{"id":2065,"date":"2026-01-28T17:37:48","date_gmt":"2026-01-28T17:37:48","guid":{"rendered":"https:\/\/opt-mvac.org\/?p=2065"},"modified":"2026-01-28T17:50:58","modified_gmt":"2026-01-28T17:50:58","slug":"opt-mvac-webinar-resag-2-farmacovigilancia-e-vigilancia-dos-eapv-relacionados-com-as-vacinas-contra-a-malaria","status":"publish","type":"post","link":"https:\/\/opt-mvac.org\/pt-pt\/opt-mvac-webinar-resag-2-farmacovigilancia-e-vigilancia-dos-eapv-relacionados-com-as-vacinas-contra-a-malaria\/","title":{"rendered":"OPT-MVAC webinar: ReSaG 2 \u2013 Farmacovigil\u00e2ncia e vigil\u00e2ncia dos EAPV relacionados com as vacinas contra a mal\u00e1ria"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"2065\" class=\"elementor elementor-2065 elementor-2037\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2fe4592 e-flex e-con-boxed e-con e-parent\" data-id=\"2fe4592\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-64f9ca9 elementor-widget elementor-widget-text-editor\" data-id=\"64f9ca9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Realizado a 9 de dezembro de 2025, o segundo webinar do Grupo Regional de Seguran\u00e7a (ReSaG) da OPT-MVAC \u2013 novamente organizado por colegas do Rabat Collaborating Center \u2013 centrou-se na farmacovigil\u00e2ncia e na vigil\u00e2ncia de Eventos Adversos P\u00f3s-Vacina\u00e7\u00e3o (EAPV) relacionados com vacinas contra a mal\u00e1ria.<\/p><p>A sess\u00e3o incluiu an\u00e1lises aprofundadas de estudos de caso reais do Benim, Burkina Faso e Gana, tendo o Rabat Collaborating Center partilhado as conclus\u00f5es de um relat\u00f3rio compilado com dados destes pa\u00edses. Juntos, os parceiros compararam as abordagens nacionais e discutiram as oportunidades para refor\u00e7ar as prioridades de farmacovigil\u00e2ncia.<\/p><p>A sess\u00e3o foi gravada com interpreta\u00e7\u00e3o simult\u00e2nea em ingl\u00eas, franc\u00eas e portugu\u00eas e est\u00e1 dispon\u00edvel para visualiza\u00e7\u00e3o <a href=\"https:\/\/us06web.zoom.us\/rec\/share\/vpRiXds2bqk0lrQ8Z9YS3vOk7UdSJ-AgJMEM_VyOoruWI3uKB1ikv5ILsVp-Cl8I.cXJV6iKOF_BGxFkI\"><strong><span style=\"color: #0000ff;\">aqui<\/span><\/strong><\/a> (password: 3*97JXaR). Outros recursos dispon\u00edveis para download incluem as <a href=\"https:\/\/opt-mvac.org\/wp-content\/uploads\/2026\/01\/OPT-MVAC-ReSaG2_Nota-de-sintese_PT.pdf\"><strong><span style=\"color: #0000ff;\">notas do webinar<\/span><\/strong><\/a> e os <a href=\"https:\/\/opt-mvac.org\/wp-content\/uploads\/2026\/01\/OPT-MVAC-webinar-ReSaG-2_Pharmacovigilance-and-surveillance-of-AEFIs-related-to-malaria-vaccines.pdf\"><strong><span style=\"color: #0000ff;\">diapositivos da apresenta\u00e7\u00e3o<\/span><\/strong><\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Realizado a 9 de dezembro de 2025, o segundo webinar do Grupo Regional de Seguran\u00e7a (ReSaG) da OPT-MVAC \u2013 novamente organizado por colegas do Rabat Collaborating Center \u2013 centrou-se na farmacovigil\u00e2ncia e na vigil\u00e2ncia de Eventos Adversos P\u00f3s-Vacina\u00e7\u00e3o (EAPV) relacionados com vacinas contra a mal\u00e1ria. A sess\u00e3o incluiu an\u00e1lises aprofundadas de estudos de caso reais [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":2040,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[39],"tags":[],"class_list":["post-2065","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recursos"],"_links":{"self":[{"href":"https:\/\/opt-mvac.org\/pt-pt\/wp-json\/wp\/v2\/posts\/2065","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opt-mvac.org\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/opt-mvac.org\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/opt-mvac.org\/pt-pt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/opt-mvac.org\/pt-pt\/wp-json\/wp\/v2\/comments?post=2065"}],"version-history":[{"count":4,"href":"https:\/\/opt-mvac.org\/pt-pt\/wp-json\/wp\/v2\/posts\/2065\/revisions"}],"predecessor-version":[{"id":2069,"href":"https:\/\/opt-mvac.org\/pt-pt\/wp-json\/wp\/v2\/posts\/2065\/revisions\/2069"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/opt-mvac.org\/pt-pt\/wp-json\/wp\/v2\/media\/2040"}],"wp:attachment":[{"href":"https:\/\/opt-mvac.org\/pt-pt\/wp-json\/wp\/v2\/media?parent=2065"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/opt-mvac.org\/pt-pt\/wp-json\/wp\/v2\/categories?post=2065"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/opt-mvac.org\/pt-pt\/wp-json\/wp\/v2\/tags?post=2065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}